Magnesium orotate

Magnesium orotate
Clinical data
AHFS/Drugs.com	Consumer Drug Information
ATC code	A12CC09 (WHO) ;
Identifiers
	IUPAC name magnesium 2,6-dioxo-3H-pyrimidine-4-carboxylate;
CAS Number	34717-03-8 ;
PubChem CID	3036905;
ChemSpider	2300801;
UNII	GI96W46M5A;
CompTox Dashboard (EPA)	DTXSID20905129 ;
ECHA InfoCard	100.047.410
Chemical and physical data
Formula	C10H6MgN4O8
Molar mass	334.483 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES [Mg+2].O=C([O-])\C1=C\C(=O)NC(=O)N1.[O-]C(=O)\C1=C\C(=O)NC(=O)N1;
	InChI InChI=1S/2C5H4N2O4.Mg/c28-3-1-2(4(9)10)6-5(11)7-3;/h21H,(H,9,10)(H2,6,7,8,11);/q;;+2/p-2; Key:QWLHYYKDLOVBNV-UHFFFAOYSA-L;
	(verify)

Magnesium orotate, the magnesium salt of orotic acid, is a mineral supplement. It can be used in treating extracellular magnesium deficiency, as well as in mitigating magnesium depletion that inhibits the binding of adenosine triphosphate via orotic acid, which provides binding sites.^[1]

References

↑ Classen HG (2004). "Magnesium orotate--experimental and clinical evidence". Romanian Journal of Internal Medicine = Revue Roumaine de Médecine Interne. 42 (3): 491–501. PMID 16366126.

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.